W Marder

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. pmc Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients
    W Marder
    Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI 48109 5358, USA
    Gynecol Endocrinol 28:624-7. 2012
  2. doi request reprint Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study
    W Marder
    University of Michigan Health System, Ann Arbor, MI, USA
    Lupus 19:1229-36. 2010

Collaborators

Detail Information

Publications2

  1. pmc Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients
    W Marder
    Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI 48109 5358, USA
    Gynecol Endocrinol 28:624-7. 2012
    ..We hypothesized that AMH would be diminished in women exposed to CYC versus women receiving adjunctive GnRH-a treatment or no CYC exposure...
  2. doi request reprint Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study
    W Marder
    University of Michigan Health System, Ann Arbor, MI, USA
    Lupus 19:1229-36. 2010
    ..5 units; p = 0.097). This pilot study does not support the use of Prasterone in mild lupus for prevention of atherosclerosis or osteoporosis, and confirms other findings of potentially harmful effects on lipids...